TSE:HTL

Hamilton Thorne (HTL) Stock Price, News & Analysis

C$1.37
+0.01 (+0.74%)
(As of 04/26/2024 ET)
Today's Range
C$1.36
C$1.37
50-Day Range
C$1.28
C$1.38
52-Week Range
C$1.05
C$1.70
Volume
36,200 shs
Average Volume
47,129 shs
Market Capitalization
C$209.28 million
P/E Ratio
N/A
Dividend Yield
1.50%
Price Target
N/A
HTL stock logo

About Hamilton Thorne Stock (TSE:HTL)

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services. In addition, it manufactures and distributes products for reproductive medicine, including clinical and laboratory equipment and disposables, as well as complete installations of ART clinics; and bench top incubators, programmable freezers, loggers, alarms, cryo storage, and software systems and sensors for the safe preservation of medical and biological specimens used in ART and cell biology applications. Further, the company offers Cell-Tek Microscope Chamber, a product for controlling temperature, air flow, humidification, and air quality; laminar flow workstations, incubators, and related products; and artificial intelligence enabled CASA software, consumables, and image analysis systems for the ART and laboratory markets, as well as acts as a value-added reseller of a range of capital equipment and consumables. It sells its products and services through a direct sales force in the United States, Germany, France, Australia, Denmark, Spain, and the United Kingdom, as well as through distributors to fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments in approximately 75 countries. The company is headquartered in Beverly, Massachusetts.

HTL Stock Price History

HTL Stock News Headlines

Hamilton Thorne (TSE:HTL) Stock Price Down 0.7%
Hamilton Thorne reports Q4 results
Better than Bitcoin? The Biotech Stock with 46,751% Potential
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Better than Bitcoin? The Biotech Stock with 46,751% Potential
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Hamilton Insurance: Q4 Earnings Snapshot
See More Headlines
Receive HTL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hamilton Thorne and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/27/2024
Next Earnings (Estimated)
5/20/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$67.23 million
Book Value
C$0.43 per share

Miscellaneous

Free Float
N/A
Market Cap
C$209.28 million
Optionable
Not Optionable
Beta
0.29
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. David B. Wolf
    Executive Chairman
  • Mr. Francesco Fragasso CPA
    Chief Financial Officer
  • Mr. Brett M. Fulton
    Senior VP & GM
  • Dr. Ekaterina Torchilin MBA
    Ph.D., President, CEO & Director
  • Mr. Thomas Kenny
    Senior Vice President Global Operations & Sustaining Engineering and Management Rep
  • Mr. Justin Jaundoo
    Vice President of Corporate Development
  • Ms. Kimberly Marolda
    Director of HR
  • Mr. Eric V. Dorman
    President of Embryotech Laboratories Inc
  • Dr. Fabian Sell
    Chief Executive Officer of Gynemed
  • Mr. Dan Ryan
    Finance Controller

HTL Stock Analysis - Frequently Asked Questions

Should I buy or sell Hamilton Thorne stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Hamilton Thorne in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" HTL shares.
View HTL analyst ratings
or view top-rated stocks.

How have HTL shares performed in 2024?

Hamilton Thorne's stock was trading at C$1.33 on January 1st, 2024. Since then, HTL stock has increased by 3.0% and is now trading at C$1.37.
View the best growth stocks for 2024 here
.

When is Hamilton Thorne's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our HTL earnings forecast
.

How do I buy shares of Hamilton Thorne?

Shares of HTL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:HTL) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners